Uncommon Denominator is the famous VC, which was founded in 2018. The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Cloud Infrastructure, Health Care. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Negotiatus, Culture Biosciences, Culture Biosciences.
The overall number of key employees were 3.
The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Uncommon Denominator, startups are often financed by Y Combinator, Social Starts, Max Ventures. The meaningful sponsors for the fund in investment in the same round are Y Combinator, Verily, TJNS Capital. In the next rounds fund is usually obtained by Alumni Ventures Group, Verily, Trail Mix Ventures.
Funds with similar focus
Fund Name | Location |
A&G Investments | Iowa, United States, Webster City |
CosmoCom, Inc. | Melville, New York, United States |
DAIICHI | Aichi Prefecture, Japan, Nagoya |
F. A. Sharf & Co. | India, Jharkhand, Ranchi |
JR Cap LLC | New York, New York, United States |
O.G. Tech Ventures | - |
Red Bull | Austria, Salzburg |
Sofia Capital | Finland, Helsinki, Southern Finland |
Vitec Group | Richmond, United States, Vermont |
Woori Financial Group | Seoul, Seoul-t'ukpyolsi, South Korea |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Kanvas Biosciences | $12M | 22 Jun 2023 | Monmouth Junction, New Jersey, United States | ||
Dandi Technologies | $3M | 13 Oct 2022 | New York, New York, United States | ||
Mytide Therapeutics | $7M | 08 Mar 2022 | Boston, Massachusetts, United States | ||
Alba Orbital | $3M | 14 May 2021 | Glasgow, Scotland, United Kingdom | ||
Upsie | $18M | 13 May 2021 | Minneapolis, Minnesota, United States | ||
Sanctuary | $3M | 10 May 2021 | New York, New York, United States | ||
Mytide Therapeutics | 27 Jan 2021 | Boston, Massachusetts, United States | |||
Vincent | $2M | 08 Dec 2020 | New York, United States | ||
Kernal Biologics | $2M | 14 Oct 2020 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Kanvas Biosciences | $12M | 22 Jun 2023 | Monmouth Junction, New Jersey, United States | ||
Dandi Technologies | $3M | 13 Oct 2022 | New York, New York, United States | ||
Mytide Therapeutics | $7M | 08 Mar 2022 | Boston, Massachusetts, United States | ||
Alba Orbital | $3M | 14 May 2021 | Glasgow, Scotland, United Kingdom | ||
Upsie | $18M | 13 May 2021 | Minneapolis, Minnesota, United States | ||
Sanctuary | $3M | 10 May 2021 | New York, New York, United States | ||
Mytide Therapeutics | 27 Jan 2021 | Boston, Massachusetts, United States | |||
Vincent | $2M | 08 Dec 2020 | New York, United States | ||
Kernal Biologics | $2M | 14 Oct 2020 | Cambridge, Massachusetts, United States |